chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Caregiver was vaccinated at 0955. During the 15 minute observation period she was reading and approximately 1006 verbalized dizziness and nausea. Stated" started getting black" Observation nurse transferred to bed. Head of bed elevated. First cycle of vitals obtained 1007 BP- 160/80 HR-72 SpO2 100%. @1010 called RRT. Vitals taken, elevated. BP-164/86 HR-72 SpO2 100%. @1013 RRT arrived , reassessed. Caregiver stated " i feel better." She declined transfer at this time, continued observation in vaccine clinic. @1023 v/s decreased BP 143/86 HR 71 SpO2 100%. @1027 she verbalized she was feeling worse. Called RRT, they arrived @1033. Caregiver was transferred to ED at 1034 last vitals results BP 143/76 HR 98 SpO2 100%.
Approximately 7 cm of induration, erythema, itching and severe tenderness.
A vaccine was administered after was left out from the night before; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A vaccine was administered after was left out from the night before) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (A vaccine was administered after was left out from the night before). At the time of the report, EXPIRED PRODUCT ADMINISTERED (A vaccine was administered after was left out from the night before) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: This report refers to a case of Expired Product Administered for mRNA-1273 (Lot #: Unknown)  with no associated AEs
Having headaches for the past couple days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Having headaches for the past couple days) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2021, the patient experienced HEADACHE (Having headaches for the past couple days). At the time of the report, HEADACHE (Having headaches for the past couple days) outcome was unknown.            No concomitant products were reported. No treatment information was reported by the reporter.
White blisters that appeared on tongue 03/08/21.  No swelling or difficulty breathing noted by patient- stated she also recently started albuterol.  Encouraged to call doctor about side effect and to go to ER or DR asap for any tongue swelling, ER for any difficulty breathing.
This is a spontaneous report from a contactable nurse via a Pfizer sales representative. This nurse reported similar events for two brothers. A male patient of unspecified age received the first single dose of TRUMENBA on an unknown date. Medical history and concomitant medications were not provided. After vaccination, on an unknown date, the patient experienced red, warm, swollen arms, vomiting and a high fever. Events outcome was unknown. Follow-up (22JAN2016): Follow-up attempts completed. No further information expected.
Experienced severe pain in both eyes hours after the second dose.   This continued for about 12 hours along with other symptoms, including fever.  Foe weeks following, the eye pain continued to come and go.  On May 26, I was diagnosed with inflamed Iris and a degradation of my eye fluid in both eyes.  I am still being treated with steroid drops.
Very sore arm; Very sore shoulder; severe headache; sick in bed; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm, shoulder pain, headache and sickness. On an unknown date, the outcome of the pain in arm, shoulder pain, headache and sickness were unknown.   It was unknown if the reporter considered the pain in arm, shoulder pain, headache and sickness to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported the case. The age at vaccination was not reported. The patient had very sore arm and shoulder, severe headache, was sick in bed for several days after 1st dose of Shingles vaccine. The patient would not receive 2nd dose of Shingles vaccine.
Patient was given Pfizer Covid 19 vaccine for 5 to 11 year old (received 10mcg dose and not 30mcg dose)
No additional AEs; ROTATEQ administered after temperature excursion.; This spontaneous report was received from a medical assistant, referring to a patient of unknown age and gender. Information regarding the patient's concurrent conditions, concomitant medications, pertinent medical history or drug reactions/allergies was not provided.  On an unspecified date, there was a temperature excursion reported for rotavirus vaccine, live, oral, pentavalent (ROTATEQ) which was improperly stored at 49.8 Fahrenheit degrees, for 2 hours. There was no previous temperature excursion.  On 20-JUN-2022, the patient was vaccinated with improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, 2 milliliter, lot #U006165, expiration date 18-OCT-2022, administered orally for prophylaxis (product storage error). No additional adverse events were reported.
20-year-old male with a past medical history of vasovagal episodes, cerebral palsy, dorsal rhizotomy and VP shunt followed by neurology, taking no medications presents to the ED for evaluation of a first-time seizure which occurred 1 hour ago 10 minutes after receiving a Covid vaccine.  Mother states that the patient receive the Covid vaccine around 11:15 AM and 10 minutes later he became very pale the e-stim to left lower and patient he had generalized body convulsions lasting less than 1 minute and turned very pale/cyanotic.  When he stopped seizing mother states that he was slightly confused as to what had happened and continued to be pale.  Patient is completely at baseline at this time answering questions appropriately, however he still complains of having dizziness with sitting up or standing. Patient is answering all questions appropriately.  He denies any numbness or tingling.  He states he generally feels slightly weak but there is no focal weakness. No headache, nausea, vomiting, diarrhea, recent head trauma, abdominal pain, chest pain or palpitations.
Developed hives and tingling around my mouth and in my tongue approximately 36 hours following the vaccine.  Usual allergy medications have been taken, nothing further has been done at this time.
Starting a week or so after receiving the vaccine, I started getting ear pain. I tried to wait it out but it got bad enough that I needed to leave work. I went to urgent care and they told me I had a middle ear infection. I was given oral antibiotics and within 2-3 days the pain stopped. I did not do anything out of the norm before this event except receive the vaccine. Also, I have a history of ear infections as a kid.
Spleen enlarged (worsening splenomegaly); Spleen enlarged (worsening splenomegaly); This is a spontaneous report from a non-contactable consumer. A female patient of an unspecified age received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration, on an unspecified date, at single dose, for COVID-19 immunisation. Medical history included ongoing Hodgkin's Lymphoma, ongoing splenomegaly (at baseline). Concomitant medications were not reported. The patient experienced spleen enlarged (worsening splenomegaly) on an unspecified date with outcome of unknown. The patient underwent lab tests and procedures which included imaging procedure: increased significantly in size on unknown date. Her oncologist was not overly convinced that her splenomegaly was related to her Hodgkin's Lymphoma, though was going to send her for splenectomy (not jet scheduled). The case was reported as non-serious.  The information on the lot/batch number has been requested.
This spontaneous report as received from a physician refers to 2 patients of unknown age. On an unknown date the patients were vaccinated with VARIVAX (Merck). It was reported that two unspecified patients, in their 60's (years of age), received VARIVAX, instead of ZOSTAVAX. No adverse effect was reported. Additional information has been requested.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 18-NOV-2015 the patient was vaccinated with M-M-R II (lot # L012479, expiration date 10-APR-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature (incorrect product storage). No adverse experienced had been reported. This is one of several reports received from the same source. Additional information has been requested.
much fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (much fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jun-2021, the patient experienced FATIGUE (much fatigue). At the time of the report, FATIGUE (much fatigue) outcome was unknown.            Concomitant drug was not reported. Treatment medication was not reported. Action taken with mRNA-1273 in response to the event was not applicable.
Partial numbness on left side of face....heavy feeling and partial ear loss confirmed with hearing test on left side ( same side as injection ).  Initially partial  ringing with certain sounds like running the vacuum cleaner or hair dryer. Started developing constant heavy ringing in left ear on 4/5/21.
A boil came on my rear. I noticed that I also got a boil on my rear in March 2021 when I received the first vaccine. I did not put two and two together that the vaccine had caused this until after the 10/30/2021 shot.
I had the usual flu symptoms and then about 12 hours after the second shot I was up in the night to find an Advil and two minutes later I fainted. This was not a result of getting up too fast. In the subsequent two weeks, I have had two episodes of feeling weak at the knees, like it is happening again. I had never fainted before this.
This case was reported by a nurse to a sales representative and described the occurrence of corneal scar in a female subject of unspecified age who was vaccinated with hepatitis be vaccine (manufacturer unspecified) for prophylaxis. On an unspecified date before 3/20/2006, the subject received a dose of hepatitis b vaccine (dose number and lot number not provided). At an unspecified time after vaccination with hepatitis b vaccine, the subject experienced an autoimmune response that resulted in corneal scarring. At the time of initial reporting, 3/20/2006, the events were ongoing. Corneal scar was assessed as medically serious by manufacturer (OMIC).
Fever, febrile seizure, red raised maculopapular rash-7-14-07-seen in ER
No reaction - patient did not know of pregnancy at time of vaccination.  Patient found out after ER visit 3 days later for persistent fever - patient was found positive.
One day post 2nd vax, induration and pruritis developed in large area surrounding injection site. No respiratory difficulty, no generalized urticaria. Treatment: Corticosteroid, elevation.
Localized reaction to varicella vaccine about 5 minutes after injection. Localized redness and hives spreading throughout body. BENADRYL administered and hives greatly improved.
Received vaccine on 1/2/2021, 32 weeks pregnant with no other medical issues. Day of the vaccine I was fine, only a sore arm. Days 2-6 I had extreme fatigue, headache all day, sore arm, body and joint aches and pains all over,  overall feeling exhausted. I was unable to work or perform tasks around the house for almost a week. Took Tylenol for headache. Symptoms lasted longer than 72 hours after vaccination. I was informed on day 4 that I had a patient who came back positive for COVID-19, I was at a low risk of exposure while taking care of her of but had been exposed within 48 hours of her positive test. Call placed to employee exposure line, I was tested via nasal swab for COVID-19 d/t symptoms lasting longer than 72 hours after receiving the vaccine. Symptoms finally resolved on 1/9/2021.
Itchy, raised hives on entire body for more than a month, still experiencing them. Doctor prescribed prednisone and anti-histamine. I have not taken the prednisone but the anti-histamine provides some but not entire relief.
This spontaneous case reported by a consumer, describes the occurrence of decreased appetite (does not want to eat today) and nausea (queasy) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 050E21A) for COVID-19 immunization. No medical information reported. On Sep 13, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Oct 11, 2021, patient had decreased appetite (does not want to eat today) and nausea (queasy). At the time of the report, decreased appetite (does not want to eat today) and nausea (queasy) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medications or treatment information reported.
Day after injection site is bright red with knot and hot - area is about 2 x 3 inches (Tetanus) aches in arm and neck.
Patient, Age 42 year old, with no known allergies or prior skin issues has experienced a rash since 8/26/21.  Despite multiple treatments, pt.'s rash continues to thrive and is worsening. Patient's vaccines were given 6/18/21 and 7/16/21.
MEDICATION REACTION (Pt got his covid shot and immediately had a reaction to it. Diaphoretic, nauseous, dizzy. Was given 4 of zofran in route.).  Comes to the emergency department today after getting his 1st Monday and a COVID-19 vaccine at 7:30 p.m. and about 5 minutes after while sitting down developing significant diaphoresis, nausea, dizziness and feeling very warm.  The symptoms lasted for about 15 minutes and then resolved.  Since then the patient has felt a little off in his stomach but has not had any difficulty breathing, difficulty swallowing, difficulty speaking, chest pain, diarrhea, rash or itchiness.  With this episode the patient did not have any changes to his vision or feel like he was going to pass out.  Patient will be given 25 of Benadryl, 125 of Solu-Medrol, 20 of famotidine of concern for possible allergic reaction.  Additionally the patient will be given a small bolus of normal saline.  Given the patient's reassuring vitals and reassuring physical exam he will simply be monitored here were sure.  I do not feel any lab workup is necessary this point this is resolved episode seems either like a mild allergic reaction or a vasovagal episode.
Initial information received from a healthcare professional on 30 September 2013 plus subsequent follow up: A 85 year old female patient had received a second dose of FLUZONE HD intramuscularly in the left deltoid region (batch number: U4761A) on 27 September 2013. The patient had codeine allergy.  Illness at the time of vaccination was leg pain and knee. On 27 September 2013, the patient felt "yucky" and then had a low grade temp on 28 September with severe leg cramps and body aches until 29 September 2013 and now feels tired and work out. She stated that also felt this way last year after the flu vaccine. She has had leg cramps in the past unrelated to the vaccine. Laboratory investigations and treatment medications were not done. On an unspecified date the patient had recovered. List of documents held by sender: none  Additional report received from a consumer on 07 November 2013. Administered person by name added. County and state where vaccine administered were added. Contact details of patient and physician was added. Any other medication received within 4 weeks was reported none. Laboratory and corrective treatment was reported none.
Pt vaccinated with DTP crying for a few hrs. Mother reported total body jerk for 5 min. Child seen by neurologist. Appeared normal upon exam.
Information has been received from a registered nurse concerning a female adult patient with a ciprofloxacin hydrochloride allergy and no other past medical history who on 10/30/02 was vaccinated with pneumococcal vaccine 23 polyvalent (lot # 643784/0676M). Concomitant therapy that day included a flu vaccine and estrogens, conjugated. On 11/1/02 the patient developed redness and erythema area on her right arm which measured 4 inches. The patient was treated with diphenhydramine hydrochloride and warm compresses. The patient sought unspecified medical attention. Additional information has been requested.
Pfizer vaccine was added to Fluad influenza vaccine and administered as one shot rather than separating the vaccines in two anatomical locations
12/13/2020: Woke up constant numbness & cold, tingling, pins/needles, electrical shocks, in both hands, fingers, & arms, tongue felt like it was burnt and cold lips.  Constant numbness & cold, tingling, pins/needles and no reflexes, in both legs and feet from the knees down. Completely lost ability to walk and would fall to the ground, need help dressing, shower, eating, basically everything! Severe constant pain. Appointment w/ my PCP 12/15/2020 & office visit 12/18/2020 reg my symptoms & Dr.  requested Brain MRI done 12/24/2020. Saw local Neurologist 12/22/2020 thought GBS disese & requested EMG test. Hospital ER 12/29/2020 sent home w/ walker 2 await EMG test.  EMG 1/4/2021, inconclusive. See more below: Hospital ER again 1/5/2021, admitted. Bloodwork, MRI's of entire spine & no answers for my symptoms. Hospital Neurologist didn't have clear diagnosis, sent me to their in-hospital rehab facility through 1/15/2021 and still unclear diagnosis. Have been home, bedridden, since that day trying to get into a larger more capable hospital. Still had all of the above symptoms mentioned, however were worse, except burnt tongue feeling stopped on 3/4/2021. Due to Covid outbreak, couldn't get appointment with Neurologists until 2/4/2021 and appointment with Neurologist until 3/2/2021.  Both requested EMG's.  On 3/24/2021 had (3) MRI's (Lumbar.Thorasic/Cervical) and EMG.  On 3/31/2021 had EMG. Both Neurologists separately diagnosed me with CIDP and both recommended IVIG treatment for this rare disease. On 4/20/2021 had Brain MRI & CAT Scan, per Neurologist.  I started IVIG treatment through the guidance of the Neurologist on 5/11/2021 with a 5 day loading dose from 5/11/2021 to 5/15/2021. Had significant side effects. Had 3 day infusion 6/21/2021 to 6/23/2021 with continued side effects and continued with IVIG infusions/treatments every 4 weeks. Changed brand of IVIG, added IV fluids, IV Benedryl, IV Steroid, and Anti Nausea push to help lessen the side effects some.  Due to decline between treatments, adjusted treatment to every 3 weeks, per the office visit/evaluation with my Neurologist on 10/7/2021.  Still bedridden, and getting infusions every 3 weeks and increased dosage of IVIG infusions in February 2022 as well.  Adjusting treatments under Neurologist care based on my symptoms and improvements, or worsening symptoms. As of March 2022 continuous treatment, have all symptoms, pain, bedridden, difficult treatments and side effects, no job since 2021, tons of medical bills, no social life, need family and friends to support with meals, house cleaning, laundry, grocery, all aspects of my life. Husband helps me daily, take to Dr. appointments and tests in wheelchair, etc. as of this form being submitting March 2022. I have been dealing with so much, I'm finally getting a chance to submit this form after continuing with lifelong infusions and possible other treatments, as there is no cure for CIDP.
Vaccine administered late afternoon 9/16. Left arm PREVNAR 13. 9/17 Fever 101.6, body aches, fatigue. 9/18 Seen in office ongoing fatigue, afebrile, 7 cm hot red localized reaction.
Chills, vomiting, diarrhea, fever to 101,  severe headache and muscle pain:  Day 2: fever to 102, muscle aches, fatigue
Next day post vax, the pt developed an area of erythema at the injection site measuring 6-cm in diameter. The erythema lasted 48 hours and resolved without treatment. The pt recovered. This is one of four pts from this facility who developed an injection site reaction following receipt of vax.
Patient was given pediatric dose 0.2 mL, instead of adult dose based on age.
Hypertension, hives on chest, arms and torso, sweating.  50 mg Benadryl administered
The location was instructed to pick up Pfizer vaccine from a store for use on 3/24/21 and 3/25/21. There was no expiration date or similar info on the packaging in which we received the vaccine and diluent. Since we were told to use the vaccine on these days only (we normally use Moderna), the assumption was that the vaccine would be within it's date/time. Our manager was informed at end-of-day on 03/25/21 that the vaccine had expired at 11:00 am that day  Consultation with Pfizer indicated that the dose did not have to be repeated for patient.
no additional AEs; temperature excursion: -14.7 C; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant medications were not reported.  On 12-MAY-2021, the patient was vaccinated with incorrectly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) (strength, exact dose, route of administration were not reported; lot number reported as S03870 verified to be not valid, expiry date reported as 31-MAY-2022) for prophylaxis.  The suspect vaccine was stored in the temperature from -50 degrees Celsius (C) to -15 C (-14.7C) for 45 minutes, in the temperature of -10.29 C for 45 minutes and in the temperature of -1.81 C for 3 hours and 30 minutes. There was previous temperature excursion of -14.7 C for 45 minutes. Digital data logger was involved. No additional adverse event was reported.
pt recvd vax 31MAR94 & 1 1/2 to 2 wks later observed a facial tick- jerks neck to lt & twitches eye about 11 times a minute; also c/o neck soreness; whole arm went numb (lt) & pain c/o clear to neck area;